Literature DB >> 23275444

Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.

Anne-Lise Steunou1, Manuelle Ducoux-Petit, Ikrame Lazar, Bernard Monsarrat, Monique Erard, Catherine Muller, Eric Clottes, Odile Burlet-Schiltz, Laurence Nieto.   

Abstract

Hypoxia-inducible factors (HIFs) are heterodimeric transcription factors that play a key role in cellular adaptation to hypoxia. HIF proteins are composed of an α subunit regulated by oxygen pressure (essentially HIF1α or HIF2α) and a constitutively expressed β subunit. These proteins are often overexpressed in cancer cells, and HIF overexpression frequently correlates with poor prognosis, making HIF proteins promising therapeutic targets. HIF proteins are involved in melanoma initiation and progression; however, the specific function of HIF2 in melanoma has not yet been studied comprehensively. Identifying protein complexes is a valuable way to uncover protein function, and affinity purification coupled with mass spectrometry and label-free quantification is a reliable method for this approach. We therefore applied quantitative interaction proteomics to identify exhaustively the nuclear complexes containing HIF2α in a human melanoma cell line, 501mel. We report, for the first time, a high-throughput analysis of the interactome of an HIF subunit. Seventy proteins were identified that interact with HIF2α, including some well-known HIF partners and some new interactors. The new HIF2α partners microphthalmia-associated transcription factor, SOX10, and AP2α, which are master actors of melanoma development, were confirmed via co-immunoprecipitation experiments. Their ability to bind to HIF1α was also tested: microphthalmia-associated transcription factor and SOX10 were confirmed as HIF1α partners, but the transcription factor AP2α was not. AP2α expression correlates with low invasive capacities. Interestingly, we demonstrated that when HIF2α was overexpressed, only cells expressing large amounts of AP2α exhibited decreased invasive capacities in hypoxia relative to normoxia. The simultaneous presence of both transcription factors therefore reduces cells' invasive properties. Knowledge of the HIF2α interactome is thus a useful resource for investigating the general mechanisms of HIF function and regulation, and here we reveal unexpected, distinct roles for the HIF1 and HIF2 isoforms in melanoma progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23275444      PMCID: PMC3591665          DOI: 10.1074/mcp.M112.020727

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  53 in total

1.  Immunoaffinity purification of mammalian protein complexes.

Authors:  Yoshihiro Nakatani; Vasily Ogryzko
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

2.  A mediator required for activation of RNA polymerase II transcription in vitro.

Authors:  P M Flanagan; R J Kelleher; M H Sayre; H Tschochner; R D Kornberg
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

3.  Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.

Authors:  Raju R Raval; Kah Weng Lau; Maxine G B Tran; Heidi M Sowter; Stefano J Mandriota; Ji-Liang Li; Christopher W Pugh; Patrick H Maxwell; Adrian L Harris; Peter J Ratcliffe
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

4.  Oxygen-regulated and transactivating domains in endothelial PAS protein 1: comparison with hypoxia-inducible factor-1alpha.

Authors:  J F O'Rourke; Y M Tian; P J Ratcliffe; C W Pugh
Journal:  J Biol Chem       Date:  1999-01-22       Impact factor: 5.157

5.  AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression.

Authors:  Y X Zeng; K Somasundaram; W S el-Deiry
Journal:  Nat Genet       Date:  1997-01       Impact factor: 38.330

6.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

7.  Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.

Authors:  S Huang; D Jean; M Luca; M A Tainsky; M Bar-Eli
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

8.  Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs.

Authors:  Michael S Wiesener; Jan Steffen Jürgensen; Christian Rosenberger; Charlotte K Scholze; Jan H Hörstrup; Christina Warnecke; Stefano Mandriota; Ingo Bechmann; Ulrich A Frei; Christopher W Pugh; Peter J Ratcliffe; Sebastian Bachmann; Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  FASEB J       Date:  2002-12-17       Impact factor: 5.191

Review 9.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

10.  Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.

Authors:  Roser Buscà; Edurne Berra; Cédric Gaggioli; Mehdi Khaled; Karine Bille; Barbara Marchetti; Raphaël Thyss; Giorgos Fitsialos; Lionel Larribère; Corine Bertolotto; Thierry Virolle; Pascal Barbry; Jacques Pouysségur; Gilles Ponzio; Robert Ballotti
Journal:  J Cell Biol       Date:  2005-06-27       Impact factor: 10.539

View more
  12 in total

1.  Proteomic Findings in Melanoma.

Authors:  Deepanwita Sengupta; Alan J Tackett
Journal:  J Proteomics Bioinform       Date:  2016-04-27

2.  Hypoxia-induced Changes in SUMO Conjugation Affect Transcriptional Regulation Under Low Oxygen.

Authors:  Georgia Chachami; Nicolas Stankovic-Valentin; Angeliki Karagiota; Angeliki Basagianni; Uwe Plessmann; Henning Urlaub; Frauke Melchior; George Simos
Journal:  Mol Cell Proteomics       Date:  2019-03-29       Impact factor: 5.911

3.  SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity.

Authors:  Saskia A Graf; Christian Busch; Anja-Katrin Bosserhoff; Robert Besch; Carola Berking
Journal:  J Invest Dermatol       Date:  2014-03-07       Impact factor: 8.551

4.  Adipocyte extracellular vesicles carry enzymes and fatty acids that stimulate mitochondrial metabolism and remodeling in tumor cells.

Authors:  Emily Clement; Ikrame Lazar; Camille Attané; Lorry Carrié; Stéphanie Dauvillier; Manuelle Ducoux-Petit; David Esteve; Thomas Menneteau; Mohamed Moutahir; Sophie Le Gonidec; Stéphane Dalle; Philippe Valet; Odile Burlet-Schiltz; Catherine Muller; Laurence Nieto
Journal:  EMBO J       Date:  2020-01-10       Impact factor: 11.598

5.  Gene expression of four targets in situ of the first trimester maternal-fetoplacental interface.

Authors:  Sandra A Founds; Donna B Stolz
Journal:  Tissue Cell       Date:  2019-11-06       Impact factor: 2.466

6.  Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer.

Authors:  Michelle S Bousquet; Jia Jia Ma; Ranjala Ratnayake; Pamela A Havre; Jin Yao; Nam H Dang; Valerie J Paul; Thomas J Carney; Long H Dang; Hendrik Luesch
Journal:  ACS Chem Biol       Date:  2016-03-03       Impact factor: 5.100

Review 7.  BRM: the core ATPase subunit of SWI/SNF chromatin-remodelling complex-a tumour suppressor or tumour-promoting factor?

Authors:  Iga Jancewicz; Janusz A Siedlecki; Tomasz J Sarnowski; Elzbieta Sarnowska
Journal:  Epigenetics Chromatin       Date:  2019-11-13       Impact factor: 4.954

Review 8.  Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance.

Authors:  Ewelina Dratkiewicz; Aleksandra Simiczyjew; Justyna Mazurkiewicz; Marcin Ziętek; Rafał Matkowski; Dorota Nowak
Journal:  Cells       Date:  2021-04-09       Impact factor: 6.600

Review 9.  Hypoxia-dependent drivers of melanoma progression.

Authors:  Simona D'Aguanno; Fabiana Mallone; Donatella Del Bufalo; Antonietta Moramarco; Marco Marenco
Journal:  J Exp Clin Cancer Res       Date:  2021-05-08

Review 10.  Protein-protein interaction networks: probing disease mechanisms using model systems.

Authors:  Uros Kuzmanov; Andrew Emili
Journal:  Genome Med       Date:  2013-04-30       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.